Precise clinical and radiological evaluation to distinguish rare sarcomas from common benign masses, preventing the "unplanned excision" (whoops surgery).
Specialized surgical techniques designed to achieve oncologically safe margins while preserving critical nerves, vessels, and functional mobility.
Collaborative care involving radiation and medical oncology to optimize local control and survival rates for high-grade soft tissue tumors.
Utilizing microsurgical techniques and local tissue flaps to restore form and function following radical tumor removal.
Soft tissue sarcomas are very rare. While local (Singapore) statistics are available through the Singapore Cancer Registry they have not been robust enough to appreciate the subtypes of soft tissue sarcomas. Nevertheless, based on the United States Cancer Statistics 2000, http://appsnccdcdcgov/uscs/ accessed in 231005, there were 186,839 (0.07%) cases of breast cancer and 187,415 cases (0.07%) of prostate cancer compared to 7,672 cases of soft tissue sarcomas (0.003%) and 2,379 (0.0008%) of all types of bone sarcomas given the United States population of the time (http://wwwcensusgov/population/www/cen2000/ accessed 231005) which was 281,421,906 resident in United states in 2000.
Sarcomas are often painless, deep-seated, and grow larger than 5cm (about the size of a golf ball). Any new or growing mass—especially those located beneath the muscle fascia—should be evaluated by a musculoskeletal oncologist before any biopsy or surgery is attempted.
An unplanned excision occurs when a sarcoma is mistakenly removed as a benign cyst. This often leaves "contaminated margins," which significantly increases the risk of recurrence and may necessitate more radical surgery later.
With modern multidisciplinary care, limb salvage is possible in over 90% of cases. By combining specialized surgery with targeted radiation, we can often achieve local tumor control while preserving the limb's strength and function.
Other links on the site of interest